| Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients DM Smadja, CL Guerin, R Chocron, N Yatim, J Boussier, N Gendron, ... Angiogenesis 23, 611-620, 2020 | 259 | 2020 |
| COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, ... Angiogenesis 24, 755-788, 2021 | 160 | 2021 |
| Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality A Philippe, R Chocron, N Gendron, O Bory, A Beauvais, N Peron, ... Angiogenesis, 1-13, 2021 | 138 | 2021 |
| Curative anticoagulation prevents endothelial lesion in COVID‐19 patients L Khider, N Gendron, G Goudot, R Chocron, C Hauw‐Berlemont, ... Journal of Thrombosis and Haemostasis 18 (9), 2391-2399, 2020 | 88 | 2020 |
| Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study JL Diehl, N Peron, R Chocron, B Debuc, E Guerot, C Hauw-Berlemont, ... Annals of intensive care 10, 1-7, 2020 | 74 | 2020 |
| Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte O Sanchez, Y Benhamou, L Bertoletti, J Constant, F Couturaud, A Delluc, ... Revue des maladies respiratoires 36 (2), 249-283, 2019 | 74 | 2019 |
| Platelet activation in critically ill COVID-19 patients N Yatim, J Boussier, R Chocron, J Hadjadj, A Philippe, N Gendron, ... Annals of intensive care 11, 1-12, 2021 | 70 | 2021 |
| Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study B Planquette, A Le Berre, L Khider, A Yannoutsos, N Gendron, M de Torcy, ... Thrombosis Research 197, 94-99, 2021 | 63 | 2021 |
| Anticoagulation before hospitalization is a potential protective factor for COVID‐19: insight from a French multicenter cohort study R Chocron, V Galand, J Cellier, N Gendron, T Pommier, O Bory, L Khider, ... Journal of the American Heart Association 10 (8), e018624, 2021 | 56 | 2021 |
| Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version O Sanchez, Y Benhamou, L Bertoletti, J Constant, F Couturaud, A Delluc, ... Revue des maladies respiratoires 36 (2), 249-283, 2019 | 52 | 2019 |
| Current concepts on endothelial stem cells definition, location, and markers SEJ Chambers, V Pathak, E Pedrini, L Soret, N Gendron, CL Guerin, ... Stem Cells Translational Medicine 10 (S2), S54-S61, 2021 | 46 | 2021 |
| D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study R Chocron, B Duceau, N Gendron, N Ezzouhairi, L Khider, A Trimaille, ... Archives of cardiovascular diseases 114 (5), 381-393, 2021 | 43 | 2021 |
| Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties E Rossi, S Poirault-Chassac, I Bieche, R Chocron, A Schnitzler, ... Stem Cell Reviews and Reports 15, 590-600, 2019 | 42 | 2019 |
| Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-dimer and correlation with right ventricular afterload G Goudot, R Chocron, JL Augy, N Gendron, L Khider, B Debuc, ... Frontiers in medicine 7, 586307, 2020 | 40 | 2020 |
| Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism E Rossi, C Goyard, A Cras, B Dizier, N Bacha, A Lokajczyk, CL Guerin, ... Thrombosis and Haemostasis 117 (10), 1908-1918, 2017 | 39 | 2017 |
| Endothelial microparticles are associated to pathogenesis of idiopathic pulmonary fibrosis NC Bacha, A Blandinieres, E Rossi, N Gendron, N Nevo, S Lecourt, ... Stem cell reviews and reports 14, 223-235, 2018 | 38 | 2018 |
| Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak L Frumholtz, JD Bouaziz, M Battistella, J Hadjadj, R Chocron, D Bengoufa, ... British Journal of Dermatology 185 (6), 1176-1185, 2021 | 37 | 2021 |
| Placental growth factor level in plasma predicts COVID‐19 severity and in‐hospital mortality DM Smadja, A Philippe, O Bory, N Gendron, A Beauvais, M Gruest, ... Journal of Thrombosis and Haemostasis 19 (7), 1823-1830, 2021 | 35 | 2021 |
| Lupus anticoagulant single positivity during the acute phase of COVID‐19 is not associated with venous thromboembolism or In‐hospital mortality N Gendron, MA Dragon‐Durey, R Chocron, L Darnige, G Jourdi, ... Arthritis & Rheumatology 73 (11), 1976-1985, 2021 | 33 | 2021 |
| Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance A Philippe, N Gendron, O Bory, A Beauvais, T Mirault, B Planquette, ... Angiogenesis 24 (3), 407-411, 2021 | 32 | 2021 |
